Down-regulation of secretion of human complement component C2 by the product of an alternatively spliced C2 messenger RNA

Journal of Immunology

Volumn 156, Issue 12, 1996, Pages 4901-4908

  Tsukamoto, Hiroshi ^a   Tousson, Albert ^b   Marchase, Richard B ^b   Volanakis, John E ^a,c  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C2;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; COMPLEMENT ACTIVATION; DOWN REGULATION; ENDOPLASMIC RETICULUM; GENE ACTIVATION; NONHUMAN; PRIORITY JOURNAL;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BREFELDIN A; CELL COMPARTMENTATION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COMPLEMENT C2; CYCLOPENTANES; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; HUMANS; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; RNA, MESSENGER;

EID: 0029934765     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Carroll, M. C., R. D. Campbell, D. R. Bentley, and R. R. Porter. 1984. A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2, and factor B. Nature 307:237.
2. Ishii, Y., Z. B. Zhu, K. J. Macon, and J. E. Volanakis. 1993. Structure of the human C2 gene. J. Immunol. 151:170.
3. Morris, K. M., D. P. Aden, B. B. Knowles, and H. R. Colten. 1982 Complement biosynthesis by the human hepatoma-derived cell line HepG2. J. Clin. Invest. 70:906.
4. Whaley, K. 1980. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J. Exp. Med. 151:501.
5. Katz, Y., F. S. Cole, and R. C. Strunk. 1988. Synergism between γ-interferon and lipopolysaccharide for synthesis of factor B, but not C2, in human fibroblasts. J. Exp. Med. 167:1.
6. Barnum, S. R., Y. Ishii, A. Agrawal, and J. E. Volanakis. 1992. Production and interferon-γ-mediated regulation of complement component C2 and factors B and D by the astroglioma cell line U105-MG. Biochem. J. 287:595.
7. Strunk, R. C., F. S. Cole, D. H. Perlmutter, and H. R. Colten. 1985. γ-interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes. J. Biol. Chem. 260:15280.
8. Littman, B. H., F. F. Dastvan, P. L. Carlson, and K. M. Sanders. 1989. Regulation of monocyte/macrophage C2 production and HLA-DR expression by IL-4(BSF-1) and IFN-γ. J. Immunol. 142:520.
9. Lappin, D. F., and K. Whaley. 1991. Modulation of complement gene expression by glucocorticoids. Biochem. J. 280:117.
10. Cheng, J., and J. E. Volanakis. 1994. Alternatively spliced transcripts of the human complement C2 gene. J. Immunol. 152:1774.
11. Smith, C. W. J., J. G. Patton, and B. Nadal-Ginard. 1989. Alternative splicing in the control of gene expression. Annu. Rev. Genet. 23:527.
12. Akama, H., C. A. C. Johnson, and H. R. Colten. 1995. Human complement protein C2: alternative splicing generates templates for secreted and intracellular C2 proteins. J. Biol. Chem. 270:2674.
13. Perlmutter, D. H., F. S. Cole, G. Goldberger, and H. R. Colten. 1984. Distinct primary translation products from human liver mRNA give rise to secreted and cell-associated forms of complement protein C2. J. Biol. Chem. 259:10380.
14. Schweizer, A., J. A. M. Fransen, T. Bachi, L. Ginsel, and H.-P. Hauri. 1988. Identification, by a monoclonal antibody, of a 53-kD protein associated with a tubulo-vesicular compartment at the cis-side of the Golgi apparatus. J. Cell Biol. 107:1643.
15. Horiuchi, T., K. J. Macon, V. J. Kidd, and J. E. Volanakis. 1990. Translational regulation of complement protein C2 expression by differential utilization of the 5′-untranslated region of mRNA. J. Biol. Chem. 265:6521.
16. Zoller, M. J., and M. Smith. 1983. Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors. Methods Enzymol. 100:468.
17. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488.
18. Tabor, S., and C. C. Richardson. 1987. DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. Proc. Natl. Acad. Sci. USA 84:4767.
19. Horiuchi, T., K. J. Macon, V. J. Kidd, and J. E. Volanakis. 1989. cDNA cloning and expression of human complement component C2. J. Immunol. 142:2105.
20. Horiuchi, T., K. J. Macon, J. A. Engler, and J. E Volanakis. 1991. Site-directed mutagenesis of the region around Cys-241 of complement component C2: evidence for a C4b-binding site. J. Immunol. 147:584.
21. Oglesby, T. J., M. A. Accavitti, and J. E. Volanakis. 1988. Evidence for a C4b binding site on the C2b domain of C2. J. Immunol. 141:926.
22. Sakai, K., and R. M. Stroud. 1973. Purification, molecular properties, and activation of C1 proesterase Cls. J. Immunol. 110:1010.
23. Velasco, A., L. Hendricks, K. W. Moreman, D. R. P. Tulsiani, O. Trouster, and M. G. Farquhar. 1993. Cell type-dependent variations in the subcellular distribution of α-mannosidase I and II. J. Cell Biol. 122:39.
24. Bentley, D. R. 1986. Primary structure of human complement component C2: Homology to two unrelated protein families. Biochem. J. 239:339.
25. Kornfield, R., and S. Kornfield. 1985. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54:631.
26. Lippincott-Schwartz, J., J. G. Donaldson, A. Schweizer, E. G. Berger, H.-P. Hauri, L. C. Yuan, and R. D. Klausner. 1990. Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell 60:821.
27. Doms, R. W., G. Russ, and J. W. Yewdell. 1989. Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum. J. Cell Biol. 109:61.
28. Schindler, R., C. Itin, M. Zerial, F. Lottspeich, and H.-P. Hauri. 1993. ERGIC-53, a membrane protein of the ER-Golgi intermediate compartment, carries an ER retention motif. Eur. J. Cell Biol. 61:1.
29. Schweizer, A., J. A. M. Fransen, K. Matter, T. E. Kreis, L. Ginsel, and H.-P. Hauri. 1990. Identification of an intermediate compartment involved in protein transport from endoplasmic reticulum to Golgi apparatus. Eur. J. Cell Biol. 53: 185.
30. Perlmutter, D. H., H. R. Colten, D. Grossberger, J. Strominger, J. G. Seidman, and D. D. Chaplin. 1985. Expression of complement proteins C2 and factor B in transfected L cells. J. Clin. Invest. 76:1449.
31. Helenius, A., T. Marquardt, and I. Braakman. 1992. The endoplasmic reticulum as a protein-folding compartment. Trends Cell Biol. 2:227.
32. Corrales, F. J., and A. R. Fersht. 1995. The folding of GroEL-bound barnase as a model for chaperonin-mediated protein folding. Proc. Natl. Acad. Sci. USA 92:5326.
33. Ou, W.-J., P. H. Cameron, D. Y. Thomas, and J. J. M. Bergeron. 1993. Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 364:771.
34. Chen, W., J. Helenius, I. Braakman, and A. Helenius. 1995. Cotranslational folding and calnexin binding during glycoprotein synthesis. Proc. Natl. Acad. Sci. USA 92:6229.
35. Tomana, M., M. Niemann, C. Garner, and J. E. Volanakis. 1985. Carbohydrate composition of the second, third and fifth components and factors B and D of human complement. Mol. Immunol. 22:107.
36. Arar, C., V. Carpentier, J.-P. Le Caer, M. Monsigny, A. Legrand, and A.-C. Roche. 1995. ERGIC-53, a membrane protein of the endoplasmic reticulum-Golgi intermediate compartment, is identical to MR60, an intracellular mannose-specific lectin of myelomonocytic cells. J. Biol. Chem. 270:3551.
37. Hauri, H.-P., and A. Schweizer. 1992. The endoplasmic reticulum-Golgi intermediate compartment. Curr. Opin. Cell Biol. 4:600.
38. Kramer, J., F. S. Rosen, H. R. Colten, K. Rajczy, and R. C. Strunk. 1993. Transin-hibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema. J. Clin. Invest. 91:1258.
39. Verpy, E., E. Couture-Tosi, E. Eldering, M. Lopes-Trascasa, P. Späth, T. Meo, and M. Tosi. 1995. Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function. J. Clin. Invest. 95:350.